| 0 |
PULMONARY ARTERIAL PRESSURE |
1 |
0.0213 |
| 1 |
EXERCISE TEST ABNORMAL |
1 |
0.0189 |
| 2 |
KLEPTOMANIA |
1 |
0.0137 |
| 3 |
DIAPHRAGMATIC INJURY |
1 |
0.0135 |
| 4 |
CATHETERISATION VENOUS |
1 |
0.0122 |
| 5 |
MYELOMALACIA |
1 |
0.0095 |
| 6 |
TRAUMATIC SHOCK |
1 |
0.0087 |
| 7 |
VISUAL PERSEVERATION |
1 |
0.0068 |
| 8 |
HISTONE ANTIBODY POSITIVE |
1 |
0.0064 |
| 9 |
INTERCOSTAL NEURALGIA |
1 |
0.0056 |
| 10 |
ANTIPHOSPHOLIPID ANTIBODIES |
1 |
0.0051 |
| 11 |
WITHDRAWAL HYPERTENSION |
1 |
0.0050 |
| 12 |
TRAUMATIC LIVER INJURY |
1 |
0.0043 |
| 13 |
HAEMATOMA EVACUATION |
1 |
0.0035 |
| 14 |
THERAPEUTIC EMBOLISATION |
1 |
0.0032 |
| 15 |
POST CONCUSSION SYNDROME |
1 |
0.0029 |
| 16 |
BIPOLAR II DISORDER |
1 |
0.0028 |
| 17 |
CHLAMYDIAL INFECTION |
2 |
0.0026 |
| 18 |
DEPENDENCE ON RESPIRATOR |
1 |
0.0025 |
| 19 |
VITAMIN D ABNORMAL |
1 |
0.0024 |
| 20 |
PORPHYRIA NON-ACUTE |
1 |
0.0023 |
| 21 |
ABDOMINAL INJURY |
1 |
0.0019 |
| 22 |
MYOGLOBINURIA |
1 |
0.0019 |
| 23 |
TOBACCO ABUSE |
1 |
0.0019 |
| 24 |
SITTING DISABILITY |
1 |
0.0016 |
| 25 |
SPINAL CORD INFECTION |
1 |
0.0015 |
| 26 |
BLOOD OESTROGEN DECREASED |
1 |
0.0014 |
| 27 |
ASEPTIC NECROSIS BONE |
1 |
0.0013 |
| 28 |
ABDOMINAL SYMPTOM |
1 |
0.0012 |
| 29 |
TONGUE MOVEMENT DISTURBANCE |
1 |
0.0012 |
| 30 |
NEPHROGENIC DIABETES INSIPIDUS |
1 |
0.0009 |
| 31 |
VICTIM OF CRIME |
1 |
0.0008 |
| 32 |
DEVICE INFUSION ISSUE |
2 |
0.0008 |
| 33 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
3 |
0.0008 |
| 34 |
FEELING GUILTY |
1 |
0.0008 |
| 35 |
ABSCESS ORAL |
1 |
0.0007 |
| 36 |
PRODUCT AVAILABILITY ISSUE |
16 |
0.0007 |
| 37 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 38 |
CERVICAL SPINAL STENOSIS |
1 |
0.0006 |
| 39 |
INJECTION SITE NECROSIS |
1 |
0.0005 |
| 40 |
CATHETERISATION CARDIAC |
2 |
0.0005 |
| 41 |
PANCREATITIS NECROTISING |
1 |
0.0004 |
| 42 |
TACHYARRHYTHMIA |
1 |
0.0004 |
| 43 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
0.0004 |
| 44 |
OBSESSIVE-COMPULSIVE DISORDER |
3 |
0.0004 |
| 45 |
TENOSYNOVITIS |
1 |
0.0004 |
| 46 |
PNEUMATOSIS INTESTINALIS |
1 |
0.0004 |
| 47 |
FIBULA FRACTURE |
1 |
0.0003 |
| 48 |
HAEMOTHORAX |
1 |
0.0003 |
| 49 |
LOSS OF EMPLOYMENT |
1 |
0.0003 |
| 50 |
INFUSION SITE EXTRAVASATION |
2 |
0.0003 |
| 51 |
ORTHOPNOEA |
1 |
0.0003 |
| 52 |
THROMBOSIS IN DEVICE |
1 |
0.0003 |
| 53 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 54 |
DIFFICULTY IN WALKING |
1 |
0.0003 |
| 55 |
WITHDRAWAL SYNDROME |
12 |
0.0003 |
| 56 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 57 |
MULTIPLE ALLERGIES |
2 |
0.0003 |
| 58 |
SUICIDAL BEHAVIOUR |
1 |
0.0002 |
| 59 |
HALLUCINATIONS, MIXED |
1 |
0.0002 |
| 60 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 61 |
SYNOVIAL CYST |
1 |
0.0002 |
| 62 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 63 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 64 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 65 |
TRISMUS |
1 |
0.0002 |
| 66 |
OVERWEIGHT |
1 |
0.0002 |
| 67 |
INTERVERTEBRAL DISC PROTRUSION |
4 |
0.0002 |
| 68 |
FAECALOMA |
1 |
0.0002 |
| 69 |
TENSION |
1 |
0.0002 |
| 70 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 71 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 72 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 73 |
TONGUE DISORDER |
1 |
0.0001 |
| 74 |
FEELING DRUNK |
1 |
0.0001 |
| 75 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 76 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 77 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 78 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 79 |
ILLNESS |
13 |
0.0001 |
| 80 |
SUBSTANCE ABUSE |
1 |
0.0001 |
| 81 |
ABNORMAL FAECES |
1 |
0.0001 |
| 82 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 83 |
RHABDOMYOLYSIS |
5 |
0.0001 |
| 84 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 85 |
FEAR |
3 |
0.0001 |
| 86 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 87 |
PANIC ATTACK |
4 |
0.0001 |
| 88 |
THINKING ABNORMAL |
2 |
0.0001 |
| 89 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 90 |
THERAPY CHANGE |
1 |
0.0001 |
| 91 |
HYPOTHERMIA |
1 |
0.0001 |
| 92 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 93 |
TRANSFUSION |
1 |
0.0001 |
| 94 |
EATING DISORDER |
2 |
0.0001 |
| 95 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 96 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 97 |
MALNUTRITION |
1 |
0.0001 |
| 98 |
SKIN INFECTION |
1 |
0.0001 |
| 99 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 100 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 101 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 102 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 103 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 104 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 105 |
ACCIDENT |
1 |
0.0001 |
| 106 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 107 |
RESTLESSNESS |
3 |
0.0001 |
| 108 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 109 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 110 |
DEPRESSION |
18 |
0.0001 |
| 111 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 112 |
NERVOUSNESS |
4 |
0.0001 |
| 113 |
BEDRIDDEN |
1 |
0.0001 |
| 114 |
ADVERSE EVENT |
7 |
0.0001 |
| 115 |
TOOTH INFECTION |
1 |
0.0001 |
| 116 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 117 |
PRODUCT TASTE ABNORMAL |
1 |
0.0001 |
| 118 |
DRUG TOXICITY |
1 |
0.0001 |
| 119 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 120 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 121 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 122 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 123 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 124 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 125 |
NEEDLE ISSUE |
2 |
0.0001 |
| 126 |
APATHY |
1 |
0.0001 |
| 127 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 128 |
IRRITABILITY |
4 |
0.0001 |
| 129 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 130 |
TENDONITIS |
1 |
0.0001 |
| 131 |
BLOOD CHOLESTEROL INCREASED |
3 |
0.0001 |
| 132 |
BRAIN FOG |
1 |
0.0001 |
| 133 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 134 |
PNEUMOTHORAX |
1 |
0.0001 |
| 135 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 136 |
MULTIPLE SCLEROSIS |
3 |
0.0001 |
| 137 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
3 |
0.0001 |
| 138 |
BACK DISORDER |
1 |
0.0001 |
| 139 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 140 |
GAIT INABILITY |
2 |
0.0001 |
| 141 |
SCAR |
1 |
0.0001 |
| 142 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 143 |
NIGHTMARE |
2 |
0.0001 |
| 144 |
DRUG INTERACTION |
9 |
0.0001 |
| 145 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 146 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 147 |
INSOMNIA |
15 |
0.0001 |
| 148 |
FEELING ABNORMAL |
13 |
0.0001 |
| 149 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 150 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 151 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 152 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 153 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 154 |
DISORIENTATION |
2 |
0.0001 |
| 155 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 156 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 157 |
INTENTIONAL SELF-INJURY |
1 |
0.0000 |
| 158 |
FEEDING DISORDER |
1 |
0.0000 |
| 159 |
VERTIGO |
3 |
0.0000 |
| 160 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 161 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 162 |
MENTAL DISORDER |
2 |
0.0000 |
| 163 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 164 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 165 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 166 |
CARDIAC DISORDER |
4 |
0.0000 |
| 167 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 168 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 169 |
LOCALISED INFECTION |
1 |
0.0000 |
| 170 |
PRESYNCOPE |
1 |
0.0000 |
| 171 |
AGITATION |
3 |
0.0000 |
| 172 |
BRONCHITIS |
3 |
0.0000 |
| 173 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 174 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
8 |
0.0000 |
| 175 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 176 |
HYPOPHAGIA |
1 |
0.0000 |
| 177 |
SINUSITIS |
4 |
0.0000 |
| 178 |
SEDATION |
1 |
0.0000 |
| 179 |
SPEECH DISORDER |
2 |
0.0000 |
| 180 |
JAUNDICE |
1 |
0.0000 |
| 181 |
MOOD ALTERED |
1 |
0.0000 |
| 182 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 183 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 184 |
HAEMOPTYSIS |
1 |
0.0000 |
| 185 |
ASTHMA |
4 |
0.0000 |
| 186 |
PAIN IN JAW |
1 |
0.0000 |
| 187 |
ANXIETY |
10 |
0.0000 |
| 188 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 189 |
CONVULSION |
2 |
0.0000 |
| 190 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 191 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 192 |
DYSSTASIA |
1 |
0.0000 |
| 193 |
APHASIA |
1 |
0.0000 |
| 194 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 195 |
SUICIDAL IDEATION |
3 |
0.0000 |
| 196 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 197 |
HEAD INJURY |
1 |
0.0000 |
| 198 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 199 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 200 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 201 |
EYE DISORDER |
1 |
0.0000 |
| 202 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 203 |
VIRAL INFECTION |
1 |
0.0000 |
| 204 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 205 |
ANGER |
1 |
0.0000 |
| 206 |
HAEMATURIA |
1 |
0.0000 |
| 207 |
HYPERKALAEMIA |
1 |
0.0000 |
| 208 |
HYPOXIA |
1 |
0.0000 |
| 209 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 210 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 211 |
ARTHRITIS |
2 |
0.0000 |
| 212 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 213 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 214 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 215 |
OSTEOPOROSIS |
1 |
0.0000 |
| 216 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 217 |
TREMOR |
4 |
0.0000 |
| 218 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 219 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 220 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 221 |
SEPTIC SHOCK |
1 |
0.0000 |
| 222 |
COVID-19 |
4 |
0.0000 |
| 223 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 224 |
WEIGHT DECREASED |
6 |
0.0000 |
| 225 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 226 |
ARRHYTHMIA |
1 |
0.0000 |
| 227 |
COMA |
1 |
0.0000 |
| 228 |
MIGRAINE |
2 |
0.0000 |
| 229 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 230 |
INFECTION |
3 |
0.0000 |
| 231 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
0.0000 |
| 232 |
CELLULITIS |
1 |
0.0000 |
| 233 |
FLUSHING |
2 |
0.0000 |
| 234 |
HAEMOGLOBIN DECREASED |
2 |
0.0000 |
| 235 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 236 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 237 |
DRUG DEPENDENCE |
3 |
0.0000 |
| 238 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 239 |
MEDICATION ERROR |
1 |
0.0000 |
| 240 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 241 |
HERPES ZOSTER |
1 |
0.0000 |
| 242 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 243 |
CHILLS |
2 |
0.0000 |
| 244 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 245 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 246 |
CHEST PAIN |
3 |
0.0000 |
| 247 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 248 |
HYPERHIDROSIS |
2 |
0.0000 |
| 249 |
RHINORRHOEA |
1 |
0.0000 |
| 250 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 251 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 252 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 253 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 254 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 255 |
BURNING SENSATION |
1 |
0.0000 |
| 256 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 257 |
INJURY |
1 |
0.0000 |
| 258 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 259 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 260 |
UNDERDOSE |
1 |
0.0000 |
| 261 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 262 |
HYPOAESTHESIA |
2 |
0.0000 |
| 263 |
HALLUCINATION |
1 |
0.0000 |
| 264 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 265 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 266 |
DRUG INEFFECTIVE |
17 |
0.0000 |
| 267 |
NAUSEA |
10 |
0.0000 |
| 268 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 269 |
TREATMENT FAILURE |
1 |
0.0000 |
| 270 |
URTICARIA |
2 |
0.0000 |
| 271 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 272 |
MYALGIA |
2 |
0.0000 |
| 273 |
BALANCE DISORDER |
1 |
0.0000 |
| 274 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 275 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 276 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 277 |
MALAISE |
5 |
0.0000 |
| 278 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 279 |
TACHYCARDIA |
1 |
0.0000 |
| 280 |
HEADACHE |
7 |
0.0000 |
| 281 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 282 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
2 |
0.0000 |
| 283 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 284 |
ASTHENIA |
4 |
0.0000 |
| 285 |
DYSPHAGIA |
1 |
0.0000 |
| 286 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 287 |
DIZZINESS |
5 |
0.0000 |
| 288 |
HYPOTENSION |
2 |
0.0000 |
| 289 |
SOMNOLENCE |
2 |
0.0000 |
| 290 |
HYPERTENSION |
2 |
0.0000 |
| 291 |
INFLUENZA |
1 |
0.0000 |
| 292 |
WEIGHT INCREASED |
2 |
0.0000 |
| 293 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 294 |
BACK PAIN |
2 |
0.0000 |
| 295 |
VOMITING |
4 |
0.0000 |
| 296 |
JOINT SWELLING |
1 |
0.0000 |
| 297 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 298 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 299 |
DRY SKIN |
1 |
0.0000 |
| 300 |
ARTHRALGIA |
3 |
0.0000 |
| 301 |
HOSPITALISATION |
1 |
0.0000 |
| 302 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 303 |
FATIGUE |
5 |
0.0000 |
| 304 |
PARAESTHESIA |
1 |
0.0000 |
| 305 |
PNEUMONIA |
2 |
0.0000 |
| 306 |
MUSCLE SPASMS |
1 |
0.0000 |
| 307 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 308 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 309 |
DYSPNOEA |
3 |
0.0000 |
| 310 |
ANAEMIA |
1 |
0.0000 |
| 311 |
ALOPECIA |
1 |
0.0000 |
| 312 |
ERYTHEMA |
1 |
0.0000 |
| 313 |
OVERDOSE |
1 |
0.0000 |
| 314 |
CONSTIPATION |
1 |
0.0000 |
| 315 |
OFF LABEL USE |
4 |
0.0000 |
| 316 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 317 |
DECREASED APPETITE |
1 |
0.0000 |
| 318 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 319 |
COUGH |
1 |
0.0000 |
| 320 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 321 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 322 |
PAIN |
2 |
0.0000 |
| 323 |
FALL |
1 |
0.0000 |
| 324 |
PRURITUS |
1 |
0.0000 |
| 325 |
DIARRHOEA |
1 |
0.0000 |